Wellgen Inc. develops food and pharmaceutical products based on the science of nutrigenomics - the study of the effects of nutrients and dietary substances on gene expression. The company uses tools such as quantitative PCR and microarray analysis to discover foods or dietary substances with distinct health-promoting activity based on their effects on gene expression. Rather than develop drugs that target single genes for therapeutic opportunities, Wellgen focuses on the modulation of multiple genes using products with a history of human food use. The company uses a proprietary gene panel that incorporates a set of genes central to the inflammatory process. Wellgen aims to discover new anti-inflammatory substances, but other applications of the company's nutrigenomic research include treatments for aging, bone and joint health, cardiovascular disease, metabolic diseases, skin disease, and diabetes.